Medsenic will be speaking at the 53rd annual congress of the French Society of Immunology
December 7-9, 2021 - Paris - Presentation of positive preclinical results of a new formulation of
arsenic trioxide for the treatment of graft-versus-host disease - cGvHD - and other severe autoimmune diseases. This innovative formulation enhances the therapeutic potential by providing positive immunomodulation